Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :2808
Small font sizeDefault font sizeIncrease font size
Read this article


    Article Cited by others


Neoadjuvant chemotherapy followed by surgical cytoreduction in advanced epithelial ovarian cancer

Deo SVS, Goyal Hemant, Shukla N K, Raina V, Kumar Lalit, Srinivas G

Year : 2006| Volume: 43| Issue : 3 | Page no: 117-121

   This article has been cited by
1 Upfront cytoreductive surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer in Indian patients
Mukur Dipi Ray, Suryanarayana S.V. Deo, Lalit Kumar, Manish Kumar Gaur
Future Oncology. 2021; 17(27): 3607
[Pubmed]  [Google Scholar] [DOI]
2 Surgical and Survival Outcomes with Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer: A Longitudinal Study in a Tertiary Cancer Center
Rekha B Raghavendrachar, Rani A Bhat, Vibhawari Dhakaria
Journal of South Asian Federation of Obstetrics and Gynaecology. 2020; 12(1): 27
[Pubmed]  [Google Scholar] [DOI]
3 PAX8: a sensitive and specific marker to identify cancer cells of ovarian origin for patients prior to neoadjuvant chemotherapy
Yue Wang,Yiying Wang,Jie Li,Zeng Yuan,Bingbing Yuan,Tingguo Zhang,Janiel M Cragun,Beihua Kong,Wenxin Zheng
Journal of Hematology & Oncology. 2013; 6(1): 60
[Pubmed]  [Google Scholar] [DOI]
4 Prognostic factors for survival after neoadjuvant chemotherapy for advanced ovarian cancer: meta-analysis
Malcolm John Farquharson,Nadeem Ahmed Siddiqui
Open Journal of Obstetrics and Gynecology. 2011; 01(03): 71
[Pubmed]  [Google Scholar] [DOI]
5 Clinical utility of image-guided peritoneal and omental biopsy
John A. Spencer, Michael J. Weston, Samir A. Saidi, Nafisa Wilkinson, Geoffrey D. Hall
Nature Reviews Clinical Oncology. 2010; 7(11): 623
[HTML Full text]  [Google Scholar] [DOI]
6 Does Neoadjuvant Chemotherapy Increase Optimal Cytoreduction Rate in Advanced Ovarian Cancer? Meta-Analysis of 21 Studies
Sokbom Kang,Byung-Ho Nam
Annals of Surgical Oncology. 2009; 16(8): 2315
[Pubmed]  [Google Scholar] [DOI]
7 Neo-adjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer treatment - A retrospective study | [Neo-adjuvantná chemoterapia s následnou IDS (interval debulking surgery) v liečbe pokročilého karcinómu ovária - Retrospektívna analýza]
Tkáčová, M., Vertaková-Krakovská, B., Belohorská, B., Miškovská, V., Helćpianska, L., Ondruš, D., Ondrušová, M., Švec, J.
Klinicka Onkologie. 2009; 22(6): 273-277
[Pubmed]  [Google Scholar]
8 Does neoadjuvant chemotherapy increase optimal cytoreduction rate in advanced ovarian cancer? Meta-analysis of 21 studies
Kang, S., Nam, B.-H.
Annals of Surgical Oncology. 2009; 16(8): 2315-2320
[Pubmed]  [Google Scholar]
9 Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer: A Retrospective Study
[Pubmed]  [Google Scholar]


  Site Map | What's new | Copyright and Disclaimer | Privacy Notice
  Online since 1st April '07
  © 2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow